Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
About Verve Therapeutics Verve Therapeutics, Inc. (Nasdaq: VERV) is a clinical-stage company developing a new class of genetic medicines for cardiovascular disease with the potential to transform ...
Verve Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference
About Verve Therapeutics Verve Therapeutics, Inc. (Nasdaq: VERV) is a clinical-stage company developing a new class of genetic medicines for cardiovascular disease with the potential to transform ...
News Medical on MSN13d
Muscle fat infiltration predicts heart disease risk better than BMI, study finds
By Dr. Chinta Sidharthan New research uncovers how fat hidden in your muscles could be a silent threat to your heart, ...